Detalhe da pesquisa
1.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol
; 33(5): 466-487, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176458
2.
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer.
Ann Oncol
; 32(12): 1597-1607, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487855
3.
Impact of early palliative care on caregivers of patients with advanced cancer: cluster randomised trial.
Ann Oncol
; 28(1): 163-168, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27687308
4.
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.
Ann Oncol
; 28(4): 874-881, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168303
5.
Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists.
Curr Oncol
; 24(2): e138-e145, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490937
6.
Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.
Curr Oncol
; 24(2): 103-110, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490924
7.
Approach to biomarker testing: perspectives from various specialties.
Curr Oncol
; 23(3): 178-83, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330346
8.
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada.
Curr Oncol
; 23(Suppl 1): S7-S13, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26985151
9.
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.
Ann Oncol
; 26(7): 1415-21, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25922063
10.
Management of egfr tki-induced dermatologic adverse events.
Curr Oncol
; 22(2): 123-32, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908911
11.
Pilot of three objective markers of physical health and chemotherapy toxicity in older adults.
Curr Oncol
; 22(6): 385-91, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26715870
12.
A population-based study of the epidemiology of pancreatic cancer: a brief report.
Curr Oncol
; 22(6): e478-84, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26715886
13.
A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.
Br J Cancer
; 110(3): 602-8, 2014 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24292447
14.
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer.
Ann Oncol
; 25(2): 409-15, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24368400
15.
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.
Curr Oncol
; 21(3): e426-33, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24940102
16.
Patients' perceptions of gene expression profiling in breast cancer treatment decisions.
Curr Oncol
; 21(2): e203-11, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24764705
17.
Population-based utilization of radiation therapy by a Canadian breast cancer cohort.
Curr Oncol
; 21(5): e715-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302042
18.
Health system costs for stage-specific breast cancer: a population-based approach.
Curr Oncol
; 21(6): 281-93, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25489255
19.
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
Lung Cancer
; 192: 107823, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763103
20.
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.
ESMO Open
; 8(4): 101587, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356358